Xilio Therapeutics
32 hedge funds and large institutions have $13.7M invested in Xilio Therapeutics in 2024 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
5.97% less ownership
Funds ownership: 45.28% → 39.31% (-6%)
Holders
32
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$1.48M | |
| 2 | +$929K | |
| 3 | +$844K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$92.9K |
| 5 |
Renaissance Technologies
New York
|
+$43.2K |
Top Sellers
| 1 | -$1.07M | |
| 2 | -$485K | |
| 3 | -$62.6K | |
| 4 |
Millennium Management
New York
|
-$54.9K |
| 5 |
PI
PFG Investments
Woodbury,
New York
|
-$32.4K |